MediciNova Depreciation & Amortization 2011-2026 | MNOV

Annual Depreciation & Amortization MediciNova

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
20.1 K	21.1 K	20.3 K	17.7 K	26.1 K	21.3 K	23.9 K	25.9 K	28.1 K	14.1 K	26.7 K	40.2 K	100 K	69.5 K	41.9 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
100 K	14.1 K	33.2 K

Quarterly Depreciation & Amortization MediciNova

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	5.18 K	-	-	-	5.35 K	-	-	-	4.1 K	-	13.4 K	8.92 K	4.43 K	-	19.8 K	12.6 K	6.45 K	-	15.5 K	10.3 K	5.06 K	-	18.3 K	12.3 K	6.13 K	-	19.8 K	13.5 K	6.69 K	-	21.5 K	14.5 K	7.22 K	-	10.8 K	8.2 K	4.1 K	-	23.3 K	18 K	9.18 K	-	30.5 K	20.5 K	10.3 K	-	91 K	67.3 K	33.6 K	-	35.5 K	16.6 K	8.94 K	-	33.2 K	23.9 K	12.5 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
91 K	4.1 K	17.6 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.77	1.68 %	$ 1.02 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.92	3.05 %	$ 6.76 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.44	2.16 %	$ 3.72 B	USA
Esperion Therapeutics ESPR	105 K	$ 2.02	5.76 %	$ 420 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Galectin Therapeutics GALT	1 K	$ 2.42	3.65 %	$ 155 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Heron Therapeutics HRTX	2.31 M	$ 1.26	6.3 %	$ 210 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 8.28	-0.84 %	$ 74.7 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.14	1.47 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.57	1.33 %	$ 3 B	USA
Jaguar Health JAGX	1.91 M	$ 0.36	-8.39 %	$ 840 K	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	8.3 M	$ 1.46	1.04 %	$ 389 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
KalVista Pharmaceuticals KALV	969 K	$ 20.08	2.29 %	$ 1.08 B	Britain
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.99	2.05 %	$ 4.92 M	Israel
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA